NEUROPHET Inc.
Founded in 2016 and listed on KOSDAQ in 2025, Neurophet develops AI brain-imaging solutions AQUA, SCALE PET, and AQUA AD.
Price
Change
Market cap
Products & technology
- Neurophet AQUAMRI-based brain neurodegeneration/damage analysis for early dementia diagnosis
- Neurophet SCALE PETAutomated quantitative analysis of PET imaging tracers
- Neurophet AQUA ADAlzheimer treatment eligibility, efficacy, and ARIA severity assessment
- Imaging CRO serviceClinical trial patient selection and quantitative efficacy analysis
Regulatory approvals
data.go.kr · openFDA2 Innovative Medical Device designations · 2024–2025 / 12 Korean MFDS device approvals · 2019–2025 / 6 US FDA 510(k) · 2022–2026
- InnovativeNeurophet AQUA AD Plus2025-08-20Innovative Medical Device designation
- Innovativeinnk-P012024-09-23Innovative Medical Device designation
- FDANeurophet SCALE PET2026-05-15
- FDANeurophet AQUA2026-05-15
- FDANeurophet AQUA AD Plus2026-01-29
- MFDSProduct name not recorded2025-08-25Product approval · Class 2인 25-4037 호
- MFDSBrain electrical stimulation system, psychiatric therapy2025-07-22Product approval · Class 3제허 25-495 호
- MFDSNeural image, computer aided detection/diagnosis software2025-05-13Product approval · Class 3제허 25-313 호
- MFDSNeural image, computer aided detection/diagnosis software2025-04-02Product approval · Class 3제허 25-224 호
- MFDSNeural image, analysis software2024-12-30Product approval · Class 2제인 24-1194 호
- FDANeurophet AQUA (V3.1)2024-10-25
- FDANeurophet AQUA2023-05-10
Show 8 more
- MFDSGuide for medical use2022-08-11Product approval · Class 1제신 22-1117 호
- FDANeurophet SCALE PET2022-08-05
- MFDSNeural image, analysis software2022-02-24Product approval · Class 2제인 22-4149 호
- MFDSBrain electrical stimulation system, psychiatric therapy2021-07-21Product approval · Class 3제허 21-621 호
- MFDSNeural image, treatment planning software2021-06-15Product approval · Class 2제인 21-4522 호
- MFDSNeural image, analysis software2020-08-20Product approval · Class 2제인 20-4771 호
- MFDSElectrode, external2020-06-16Product approval · Class 1제신 20-877 호
- MFDSNeural image, treatment planning software2019-02-18Product approval · Class 2제인 19-4106 호
Companies approved for the same productsMedical AI
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
JLK offers the stroke AI solution MEDIHUB STROKE and holds 78 global regulatory approvals, including US FDA and Japan PMDA clearances.
KOSDAQ-listed holding company making medical devices and biologics including bone graft rhBMP2 and knee implant TKR.
Founded in 2012, Coreline Soft provides the AI-based chest CT diagnostic aid suite AVIEW for lung nodules, COPD, and coronary calcification.
Founded in 1964 and KOSPI-listed in 1991, Shinhung manufactures and distributes dental equipment and materials.
Founded in 2001 and KOSDAQ-listed in 2022, Bistos manufactures fetal, neonatal, and patient monitoring medical devices.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Spinal implant device maker founded 2008, listed on KOSDAQ 2016; produces Cervical and Thoraco Lumbar Cage, Screw, and Plate products.
Founded in 1995 and listed on KOSDAQ in 2014, Mediana is a hospital medical device maker developing and manufacturing patient monitors and automated external defibrillators under its own brand and via ODM.
Organ Eco Tech, founded in 2006 and KONEX-listed in 2016, manufactures spinal implants.
KOSDAQ-listed dental medical device company offering the RAYSCAN digital diagnostic system and RAYDENT digital treatment solutions.
Founded in 1982 and KOSDAQ-listed in 2008, Sewoon Medical manufactures medical aspirators and catheters/tubes.
Founded in 2014, VUNO provides AI-based vital-sign and medical imaging diagnostic solutions, including VUNO Med-DeepCARS and VUNO Med-Fundus AI.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition